(+)-catechin multiple interactions ISO RGD:1318576 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of FOXP1 mRNA CTD PMID:24763279 (-)-demecolcine increases expression ISO RGD:1318576 6480464 Demecolcine results in increased expression of FOXP1 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1318576 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FOXP1 mRNA CTD PMID:22079256 (S)-nicotine decreases expression ISO RGD:1318577 6480464 Nicotine results in decreased expression of FOXP1 mRNA CTD PMID:21955143 1,2-dichloroethane increases expression ISO RGD:1318577 6480464 ethylene dichloride results in increased expression of FOXP1 mRNA CTD PMID:28960355 17beta-estradiol affects expression ISO RGD:1318576 6480464 Estradiol affects the expression of FOXP1 mRNA CTD PMID:22574217 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1318577 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1318577 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1318577 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOXP1 mRNA CTD PMID:24058054 , PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FOXP1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOXP1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318577 6480464 Tetrachlorodibenzodioxin affects the expression of FOXP1 mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of FOXP1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of FOXP1 mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO RGD:1318577 6480464 n-butoxyethanol results in decreased expression of FOXP1 mRNA CTD PMID:19812364 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1318576 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FOXP1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FOXP1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1318576 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of FOXP1 gene CTD PMID:31601247 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:1318576 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of FOXP1 mRNA alternative form CTD PMID:35435490 4-hydroxynon-2-enal decreases expression ISO RGD:1318577 6480464 4-hydroxy-2-nonenal results in decreased expression of FOXP1 mRNA CTD PMID:19191707 4-vinylcyclohexene dioxide affects expression ISO RGD:1318577 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of FOXP1 mRNA CTD PMID:20829426 acrolein multiple interactions ISO RGD:1318576 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FOXP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FOXP1 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of FOXP1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1318577 6480464 Aflatoxin B1 results in increased expression of FOXP1 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1318576 6480464 Aflatoxin B1 results in increased methylation of FOXP1 gene more ... CTD PMID:27153756 , PMID:30157460 aldehydo-D-glucose multiple interactions ISO RGD:1318576 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]] more ... CTD PMID:31494106 aldehydo-D-glucose decreases expression ISO RGD:1318576 6480464 Glucose results in decreased expression of FOXP1 mRNA, Glucose results in decreased expression of FOXP1 protein CTD PMID:31494106 all-trans-retinoic acid increases expression ISO RGD:1318576 6480464 Tretinoin results in increased expression of FOXP1 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of FOXP1 mRNA CTD PMID:20488242 alpha-pinene multiple interactions ISO RGD:1318576 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FOXP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FOXP1 mRNA CTD PMID:32699268 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of FOXP1 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:1318576 6480464 aristolochic acid I results in decreased expression of FOXP1 mRNA, aristolochic acid I results in decreased expression of FOXP1 protein CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1318577 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of FOXP1 mRNA CTD PMID:23650126 arsane increases methylation ISO RGD:1318576 6480464 Arsenic results in increased methylation of FOXP1 promoter CTD PMID:21291286 arsane affects methylation ISO RGD:1318576 6480464 Arsenic affects the methylation of FOXP1 gene CTD PMID:25304211 arsenic atom increases methylation ISO RGD:1318576 6480464 Arsenic results in increased methylation of FOXP1 promoter CTD PMID:21291286 arsenic atom affects methylation ISO RGD:1318576 6480464 Arsenic affects the methylation of FOXP1 gene CTD PMID:25304211 benzo[a]pyrene decreases expression ISO RGD:1318576 6480464 Benzo(a)pyrene results in decreased expression of FOXP1 mRNA CTD PMID:20064835 benzo[a]pyrene increases methylation ISO RGD:1318576 6480464 Benzo(a)pyrene results in increased methylation of FOXP1 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1318576 6480464 Benzo(a)pyrene affects the methylation of FOXP1 5' UTR, Benzo(a)pyrene affects the methylation of FOXP1 intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1318577 6480464 Benzo(a)pyrene results in decreased methylation of FOXP1 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1318577 6480464 Benzo(a)pyrene results in decreased expression of FOXP1 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1318576 6480464 7 more ... CTD PMID:20382639 Benzo[k]fluoranthene decreases expression ISO RGD:1318577 6480464 benzo(k)fluoranthene results in decreased expression of FOXP1 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1318577 6480464 Diethylhexyl Phthalate results in decreased expression of FOXP1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1318577 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of FOXP1 mRNA] CTD PMID:19850644 bisphenol A decreases expression ISO RGD:1318576 6480464 bisphenol A results in decreased expression of FOXP1 mRNA CTD PMID:22576693 bisphenol A affects methylation ISO RGD:1318576 6480464 bisphenol A affects the methylation of FOXP1 gene CTD PMID:31601247 bisphenol A affects methylation ISO RGD:1318577 6480464 bisphenol A affects the methylation of FOXP1 promoter CTD PMID:27334623 bisphenol A multiple interactions ISO RGD:1318576 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FOXP1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FOXP1 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FOXP1 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FOXP1 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1318576 6480464 bisphenol A results in increased methylation of FOXP1 gene CTD PMID:22576693 , PMID:25663935 bisphenol F multiple interactions ISO RGD:1318576 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FOXP1 mRNA CTD PMID:28628672 cadmium atom multiple interactions ISO RGD:1318576 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXP1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1318576 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXP1 mRNA CTD PMID:35301059 carbon nanotube decreases expression ISO RGD:1318577 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1318576 6480464 CGP 52608 promotes the reaction [RORA protein binds to FOXP1 gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO RGD:1318577 6480464 Chlorpyrifos results in decreased expression of FOXP1 mRNA CTD PMID:32715474 chromium(6+) decreases expression ISO RGD:1318576 6480464 chromium hexavalent ion results in decreased expression of FOXP1 mRNA CTD PMID:30690063 cisplatin multiple interactions ISO RGD:1318576 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of FOXP1 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1318576 6480464 Cisplatin results in decreased expression of FOXP1 mRNA CTD PMID:27392435 cocaine increases expression ISO RGD:1318577 6480464 Cocaine deficiency results in increased expression of FOXP1 mRNA CTD PMID:27126842 copper(II) sulfate increases expression ISO RGD:1318576 6480464 Copper Sulfate results in increased expression of FOXP1 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1318577 6480464 Asbestos, Crocidolite results in decreased expression of FOXP1 mRNA CTD PMID:29279043 cyclosporin A increases expression ISO RGD:1318576 6480464 Cyclosporine results in increased expression of FOXP1 mRNA CTD PMID:25562108 D-glucose multiple interactions ISO RGD:1318576 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]] more ... CTD PMID:31494106 D-glucose decreases expression ISO RGD:1318576 6480464 Glucose results in decreased expression of FOXP1 mRNA, Glucose results in decreased expression of FOXP1 protein CTD PMID:31494106 dexamethasone increases expression ISO RGD:1318577 6480464 Dexamethasone results in increased expression of FOXP1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1318576 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FOXP1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FOXP1 mRNA CTD PMID:28628672 dexamethasone decreases expression ISO RGD:1318576 6480464 Dexamethasone results in decreased expression of FOXP1 mRNA CTD PMID:25047013 dibutyl phthalate increases expression ISO RGD:1318577 6480464 Dibutyl Phthalate results in increased expression of FOXP1 mRNA CTD PMID:21266533 disodium selenite increases expression ISO RGD:1318576 6480464 Sodium Selenite results in increased expression of FOXP1 mRNA CTD PMID:18175754 diuron decreases expression EXP 6480464 Diuron results in decreased expression of FOXP1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1318576 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXP1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1318576 6480464 Doxorubicin results in decreased expression of FOXP1 mRNA CTD PMID:29803840 ethanol decreases expression ISO RGD:1318577 6480464 Ethanol results in decreased expression of FOXP1 mRNA CTD PMID:21955143 fenthion increases expression ISO RGD:1318577 6480464 Fenthion results in increased expression of FOXP1 mRNA CTD PMID:34813904 folic acid decreases expression ISO RGD:1318577 6480464 Folic Acid results in decreased expression of FOXP1 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1318576 6480464 Formaldehyde results in increased expression of FOXP1 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1318576 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FOXP1 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of FOXP1 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of FOXP1 mRNA CTD PMID:33387578 glucose decreases expression ISO RGD:1318576 6480464 Glucose results in decreased expression of FOXP1 mRNA, Glucose results in decreased expression of FOXP1 protein CTD PMID:31494106 glucose multiple interactions ISO RGD:1318576 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]] more ... CTD PMID:31494106 hydralazine multiple interactions ISO RGD:1318576 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of FOXP1 mRNA CTD PMID:17183730 indometacin multiple interactions ISO RGD:1318576 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FOXP1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FOXP1 mRNA CTD PMID:28628672 leflunomide increases expression ISO RGD:1318576 6480464 leflunomide results in increased expression of FOXP1 mRNA CTD PMID:28988120 menadione affects expression ISO RGD:1318576 6480464 Vitamin K 3 affects the expression of FOXP1 mRNA CTD PMID:20044591 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of FOXP1 mRNA CTD PMID:30467583 methidathion affects expression ISO RGD:1318577 6480464 methidathion affects the expression of FOXP1 mRNA CTD PMID:34813904 methoxychlor affects expression ISO RGD:1318577 6480464 Methoxychlor affects the expression of FOXP1 mRNA CTD PMID:20829426 methylmercury chloride increases expression ISO RGD:1318576 6480464 methylmercuric chloride results in increased expression of FOXP1 mRNA CTD PMID:28001369 morphine increases expression ISO RGD:1318577 6480464 Morphine results in increased expression of FOXP1 mRNA CTD PMID:21955143 morphine decreases expression ISO RGD:1318577 6480464 Morphine deficiency results in decreased expression of FOXP1 mRNA CTD PMID:27126842 nicotine decreases expression ISO RGD:1318577 6480464 Nicotine results in decreased expression of FOXP1 mRNA CTD PMID:21955143 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FOXP1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1318576 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FOXP1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1318577 6480464 Acetaminophen affects the expression of FOXP1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FOXP1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1318576 6480464 Acetaminophen results in decreased expression of FOXP1 mRNA CTD PMID:21420995 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 PCB138 multiple interactions ISO RGD:1318577 6480464 [2 more ... CTD PMID:25510870 phenobarbital decreases expression ISO RGD:1318577 6480464 Phenobarbital results in decreased expression of FOXP1 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1318576 6480464 Phenylmercuric Acetate results in increased expression of FOXP1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1318576 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXP1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1318576 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FOXP1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1318577 6480464 pirinixic acid results in increased expression of FOXP1 mRNA CTD PMID:17426115 pirinixic acid multiple interactions ISO RGD:1318577 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FOXP1 mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO RGD:1318576 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FOXP1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1318576 6480464 potassium chromate(VI) results in decreased expression of FOXP1 mRNA CTD PMID:22079256 , PMID:22714537 propiconazole decreases expression ISO RGD:1318577 6480464 propiconazole results in decreased expression of FOXP1 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1318576 6480464 Quercetin results in decreased expression of FOXP1 mRNA CTD PMID:21632981 rifampicin increases expression ISO RGD:1318576 6480464 Rifampin results in increased expression of FOXP1 mRNA CTD PMID:24552687 rotenone increases expression EXP 6480464 Rotenone results in increased expression of FOXP1 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1318576 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXP1 mRNA CTD PMID:27188386 silver atom decreases expression ISO RGD:1318577 6480464 Silver results in decreased expression of FOXP1 mRNA CTD PMID:27131904 silver atom increases expression ISO RGD:1318576 6480464 Silver results in increased expression of FOXP1 mRNA CTD PMID:26014281 silver(0) decreases expression ISO RGD:1318577 6480464 Silver results in decreased expression of FOXP1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1318576 6480464 Silver results in increased expression of FOXP1 mRNA CTD PMID:26014281 sirolimus decreases expression ISO RGD:1318576 6480464 Sirolimus results in decreased expression of FOXP1 protein CTD PMID:25663935 sodium arsenate increases expression ISO RGD:1318577 6480464 sodium arsenate results in increased expression of FOXP1 mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO RGD:1318577 6480464 sodium arsenite results in decreased expression of FOXP1 mRNA CTD PMID:36209798 Stanolone benzoate affects expression EXP 6480464 stanolone benzoate affects the expression of FOXP1 mRNA, stanolone benzoate affects the expression of FOXP1 protein CTD PMID:25247470 succimer multiple interactions ISO RGD:1318577 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FOXP1 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FOXP1 mRNA CTD PMID:21641980 , PMID:26378955 tetrachloromethane affects expression ISO RGD:1318577 6480464 Carbon Tetrachloride affects the expression of FOXP1 mRNA CTD PMID:17484886 titanium dioxide increases expression ISO RGD:1318577 6480464 titanium dioxide results in increased expression of FOXP1 mRNA CTD PMID:23557971 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of FOXP1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FOXP1 mRNA CTD PMID:25729387 triclosan decreases expression ISO RGD:1318576 6480464 Triclosan results in decreased expression of FOXP1 mRNA CTD PMID:30510588 triptonide increases expression ISO RGD:1318577 6480464 triptonide results in increased expression of FOXP1 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1318577 6480464 troglitazone results in decreased expression of FOXP1 mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:1318577 6480464 Tungsten results in decreased expression of FOXP1 mRNA CTD PMID:30912803 valproic acid multiple interactions ISO RGD:1318576 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of FOXP1 mRNA CTD PMID:17183730 valproic acid decreases expression ISO RGD:1318576 6480464 Valproic Acid results in decreased expression of FOXP1 mRNA CTD PMID:28001369 valproic acid increases expression ISO RGD:1318576 6480464 Valproic Acid results in increased expression of FOXP1 mRNA CTD PMID:24383497 , PMID:24935251 valproic acid affects expression ISO RGD:1318576 6480464 Valproic Acid affects the expression of FOXP1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1318577 6480464 Valproic Acid results in decreased expression of FOXP1 mRNA CTD PMID:19136453 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of FOXP1 mRNA CTD PMID:23034163 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of FOXP1 gene CTD PMID:31682807 vincristine increases expression ISO RGD:1318576 6480464 Vincristine results in increased expression of FOXP1 mRNA CTD PMID:23649840 wortmannin decreases expression ISO RGD:1318576 6480464 wortmannin results in decreased expression of FOXP1 protein CTD PMID:25663935